GLP-1 Agonists: The Medical Revolution Beyond Weight Loss In this episode, we delve into the revolutionary class of medications known as GLP-1 agonists
Compounded products have not undergone the FDA's full review process as finished products
GLP-1 agonists are a class of medications traditionally prescribed for managing type 2 diabetes
Always disclose all medications, including over-the-counter products and supplements, to ensure comprehensive safety assessment
Overall, the findings from these two recently completed cardiovascular outcomes trials suggest that the increases in HR associated with the short-acting GLP-1 RA, lixisenatide, or the long-acting GLP-1 RA, liraglutide, do not lead to an increased risk of major adverse cardiac events in patients with T2DM and high cardiovascular risk
BPC 157 Administration and Use Considerations Because BPC-157 is associated with regulatory and compounding uncertainty , its use is not based on standardized clinical guidelines